[1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003 Aug;362(9384):629-39 DOI: 10.1016/S0140-6736(03)14184-010.1016/S0140-6736(03)14184-0]Search in Google Scholar
[2. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004 Mar;15(3):722-32 DOI: 10.1097/01. ASN.0000113552.59155.7210.1097/01]Search in Google Scholar
[3. Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol. 2009 Aug;24(28):1525-32 DOI: 10.1007/s00467-009-1138-510.1007/s00467-009-1138-519280229]Search in Google Scholar
[4. Kerti A, Csohány R, Szabó A, Arkossy O, Sallay P, Moriniére V, et al. NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2013 May;28(5):751-7 DOI: 10.1007/s00467-012-2379-210.1007/s00467-012-2379-223242530]Search in Google Scholar
[5. Philippe A, Nevo F, Esquivel EL, Reklaityte D, Gribouval O, Tete MJ, et al. Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2008 Oct;19(10):1871-8 DOI: 10.1681/ASN.200801005910.1681/ASN.2008010059255157218614772]Search in Google Scholar
[6. Santin S, Bullich G, Tazon-Vega B, Garcia-Maset R, Gimenez I, Silva I, et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011 May;6(5):1139-48 DOI: 10.2215/CJN.0526061010.2215/CJN.05260610308778121415313]Search in Google Scholar
[7. Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J. Steroidresistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant. 2007 Aug;22(8):2183-93 DOI: 10.1093/ndt/gfm09210.1093/ndt/gfm09217504846]Search in Google Scholar
[8. Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010 Sep;25(3):1621-32 DOI: 10.1007/s00467-010-1495-010.1007/s00467-010-1495-0290844420333530]Search in Google Scholar
[9. Chernin G, Vega-Warner V, Schoeb DS, Heeringa SF, Ovunc B, Saisawat P, et al. Genotype/Phenotype Correlation in Nephrotic Syndrome Caused by WT1 Mutations. Clin J Am Soc Nephrol. 2010 Sep;5(9):1655-62 DOI: 10.2215/CJN.0935120910.2215/CJN.09351209297440820595692]Search in Google Scholar
[10. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, et al. Specific podocin mutations correlate with age of onset in steroidresistant nephrotic syndrome. J Am Soc Nephrol. 2008 Feb;19(2):365-71 DOI: 10.1681/ASN.200704045210.1681/ASN.2007040452239674918216321]Search in Google Scholar
[11. Hoyer PF, Vester U, Becker JU. Steroid-Resistant Nephrotic Syndrome. In: Schaefer F, Geary DF, Comprehensive Pediatric Nephrology, Mosby Inc., Philadelphia, 2008;257-67 DOI: 10.1016/B978-0-323-04883-5.50022-210.1016/B978-0-323-04883-5.50022-2]Search in Google Scholar
[12. Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010 Nov;5(11):2075-84 DOI: 10.2215/CJN.0119021010.2215/CJN.01190210300177320798252]Search in Google Scholar
[13. Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, et al. Mutations in the Wilms’ tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res. 2006 Feb;59(2):325-31 DOI: 10.1203/01. pdr.0000196717.94518.f0]Search in Google Scholar
[14. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome Kidney Int. 2004 Aug;66(2):564-70 DOI: 10.1111/j.1523-1755.2004.00775.x10.1111/j.1523-1755.2004.00775.x15253707]Search in Google Scholar
[15. Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 2004 Aug;66(2):571-9 DOI: 10.1111/j.1523-1755.2004.00776.x10.1111/j.1523-1755.2004.00776.x15253708]Search in Google Scholar
[16. Loirat C, André JL, Champigneulle J, Acquaviva C, Chantereau D, Bourquard R, et al. WT1 splice site mutation in a 46,XX female with minimal-change nephrot ic syndrome and Wilms’ tumour. Nephrol Dial Transplant. 2003 Apr;18(4):823-5 DOI: 10.1093/ndt/gfg04110.1093/ndt/gfg04112637656]Search in Google Scholar
[17. Rood IM, Deegens JKJ, Wetzels JFM. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant. 2012 Mar;27(3):882-90 DOI: 10.1093/ndt/gfr77110.1093/ndt/gfr77122334613]Search in Google Scholar
[18. Lipska BS, Ranchin B, Iatropoulos P, Gellermann J, Melk A, Ozaltin F, et al. Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int. 2014May;85(5):1169-78 DOI: 10.1038/ki.2013.519 10.1038/ki.2013.51924402088]Search in Google Scholar